7,653.75

+39.75

+0.52%

52,224.00

+306.00

+0.59%

28,772.00

+238.00

+0.83%

Russell 2000 Futures

2,843.00

+21.70

+0.77%

4.9290

-0.0600

-1.20%

18.96

-0.46

-2.37%

3,915.80

+16.90

+0.43%

77,785.97

-44.10

-0.06%

Crude Oil Dec 26

99.39

-4.73

-4.54%

US Private Equity

10,850.63

-82.20

-0.75%

NasdaqCM - Nasdaq Real Time Price USD

Gelteq Limited (GELS)

0.4901 -0.0159 (-3.14%)

At close: October 30 at 4:00:01 PM EDT

Loading Chart for GELS

Chart Range Bar

Interval:

In partnership with ChartIQ

Could Gelteq’s (GELS) Gel Improve Oral Drug Delivery?

Could Gelteq’s (GELS) Gel Improve Oral Drug Delivery?

Gelteq Provides Corporate Update: Launching Veterinary and Human Clinical Trials, Pharmaceutical Pipeline Expanding Across Multiple Programs

Gelteq Provides Corporate Update: Launching Veterinary and Human Clinical Trials, Pharmaceutical Pipeline Expanding Across Multiple Programs

Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway

Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway

Gelteq Announces USD $3.5 Million Strategic Debt Financing to Accelerate Commercialization and Support Revenue Growth

Gelteq Announces USD $3.5 Million Strategic Debt Financing to Accelerate Commercialization and Support Revenue Growth

Gelteq Successfully Completes Veterinary Palatability Trials with Kemin, Further Validating Gelteq® Technology for Animal Health Applications

Gelteq Successfully Completes Veterinary Palatability Trials with Kemin, Further Validating Gelteq® Technology for Animal Health Applications

Healthy Extracts Q1 2026 Net Revenue Up 73% to Record $1.6 Million, Driving Positive EBITDA

Gelteq Establishes Center of Excellence in China to Accelerate Product Development and Commercial Expansion

Gelteq Establishes Center of Excellence in China to Accelerate Product Development and Commercial Expansion

Q1 Virtual Investor Summit Presentations Now Available On Demand

Q1 Virtual Investor Summit Presentations Now Available On Demand

Investor Summit Announces Q1 Presenter Line Up (Presentations 3/25, 1-on-1s 3/26)

Investor Summit Announces Q1 Presenter Line Up (Presentations 3/25, 1-on-1s 3/26)

Gelteq and Healthy Extracts to Expand Gel-Based Nutrition Technologies with New Strategic Manufacturing & Commercial Partnership

Gelteq and Healthy Extracts to Expand Gel-Based Nutrition Technologies with New Strategic Manufacturing & Commercial Partnership

Gelteq announces preclinical results on medicinal cannabinoid absorption

Gelteq announces preclinical results on medicinal cannabinoid absorption

Mobilize your Website

View Site in Mobile | Classic

Share by: